Literature DB >> 36038764

The effect of hematopoietic stem cell transplantation on fertility and strategies for improvement.

Brittany File1, Mia Gergis2, Usama Gergis3.   

Abstract

Ovarian dysfunction is an important consequence of hematopoietic stem cell transplantation (HCT). Premature ovarian failure and infertility can severely impact the quality of life for the increasing number of female long-term survivors of HCT. Here, we review the impact of HCT on ovarian function, post-transplant fertility and birth outcomes, and the contemporaneous strategies to preserve fertility for these patients.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID： 36038764     DOI： 10.1038/s41409-022-01792-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


  28 in total

Review 1.  Nonmalignant late effects after allogeneic stem cell transplantation.

Authors:  Gérard Socié; Nina Salooja; Amnon Cohen; Attilio Rovelli; Enric Carreras; Anna Locasciulli; Elisabeth Korthof; Joachim Weis; Vincent Levy; André Tichelli
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

2.  Function of the hypothalamic-pituitary-gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases.

Authors:  Maria Somali; Vassilios Mpatakoias; Avraam Avramides; Ioanna Sakellari; Panayotis Kaloyannidis; Christos Smias; Achilleas Anagnostopoulos; Anargyros Kourtis; David Rousso; Dimitrios Panidis; Apostolos Vagenakis
Journal:  Gynecol Endocrinol       Date:  2005-07       Impact factor: 2.260

3.  Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

Authors:  Yee Chung Cheng; Rima M Saliba; Gabriela Rondón; Sergio A Giralt; Karen H Lu; Diane C Bodurka; David M Gershenson; Richard E Champlin; Naoto T Ueno
Journal:  Haematologica       Date:  2005-12       Impact factor: 9.941

4.  Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey.

Authors:  N Salooja; R M Szydlo; G Socie; B Rio; R Chatterjee; P Ljungman; M T Van Lint; R Powles; G Jackson; M Hinterberger-Fischer; H J Kolb; J F Apperley
Journal:  Lancet       Date:  2001-07-28       Impact factor: 79.321

5.  Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence.

Authors:  Pascale Jadoul; Ellen Anckaert; Ann Dewandeleer; Mélanie Steffens; Marie-Madeleine Dolmans; Christiane Vermylen; Johan Smitz; Jacques Donnez; Dominique Maiter
Journal:  Fertil Steril       Date:  2011-05-07       Impact factor: 7.329

6.  Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation.

Authors:  Mahiru Kawano; Hiroko Komura; Haruna Kawaguchi; Shoko Shimizu; Namiko Yada-Hashimoto; Mariko Shimizu; Maho Sato; Masami Inoue; Shinobu Ida; Yuri Etani; Yasuko Shoji; Mariko Nakacho; Kenjiro Sawada; Tadashi Kimura; Nobuaki Mitsuda; Hirohisa Kurachi
Journal:  Gynecol Endocrinol       Date:  2016-11-03       Impact factor: 2.260

7.  Human ovarian reserve from conception to the menopause.

Authors:  W Hamish B Wallace; Thomas W Kelsey
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

8.  Ovarian function following marrow transplantation for aplastic anemia or leukemia.

Authors:  J E Sanders; C D Buckner; D Amos; W Levy; F R Appelbaum; K Doney; R Storb; K M Sullivan; R P Witherspoon; E D Thomas
Journal:  J Clin Oncol       Date:  1988-05       Impact factor: 44.544

Review 9.  Effects of cancer treatment on ovarian function.

Authors:  Jaymeson S Stroud; David Mutch; Janet Rader; Matt Powell; Premal H Thaker; Perry W Grigsby
Journal:  Fertil Steril       Date:  2008-09-06       Impact factor: 7.329

10.  Ovarian function after autologous bone marrow transplantation.

Authors:  A D Schimmer; M Quatermain; K Imrie; V Ali; J McCrae; A K Stewart; M Crump; C Derzko; A Keating
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.